0位追蹤者
2007成立於
關於 Catalent, Inc.
Catalent, Inc., is an American pharmaceutical company headquartered in Tampa, Florida. It operates as a privately held independent subsidiary of Novo Holdings A/S. It is a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products. It has over 50 facilities on four continents and has supported more than half the products approved by the Food and Drug Administration in the last ten years. Annually, it produces 70 billion doses for 8,000 products. The company's major customers include Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Haleon, Novo Nordisk, Moderna, Pfizer, and Sarepta Therapeutics.
Source: Wikipedia
產業Pharmaceutical Preparations
總部14 SCHOOLHOUSE ROAD, SOMERSET, NJ 08873
成立時間2007
法律形式C Corporation
狀態營運中
關鍵數據
法律資訊
| 法定名稱 | Catalent, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1596783在 SEC EDGAR 上查看 ↗ |
| EIN | 20-8737688 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 14 SCHOOLHOUSE ROAD, SOMERSET, NJ 08873 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日